Board meeting set to approve September quarter and half-year results

Results View source PDF Explain this filing

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.6%Reaction day

₹469.65

prior close

₹460.65

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+3.2% vs market

Healthcare Research Analytics & Technology peers, median of 5sector-2.1%+5.7% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 5.7 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.9

10m

+1.2

15m

+2.5

30m

+2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.6+0.4+3.2-2.1+5.7

Next day

+8.8+2.1+6.7+0.4+8.4

+8.6pendingpending+3.6+5.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vimta Labs will hold a board meeting on 30 October 2026 to approve unaudited results for the quarter and six months ended 30 September 2026. Trading has been closed since 1 October and will remain closed until 48 hours after the results are announced. No financial figures or auditor change is disclosed.

Likely market impact

No earnings figures are disclosed, so there is no clear fundamental signal yet. The stock may react to the results published after the meeting.